Biotech · Private company
Alessa Therapeutics Inc.
Track this companyFree. Adds Alessa Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- bicalutamidePhase 1 · Prostate AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Bicalutamide implantPhase 1 · Prostate AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- enzalutamidePhase 1 · Prostate AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Stereotactic body radiation therapyPhase 1 · Prostate AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Enzalutamide Implants (Enolen) in Patients With Prostate CancerPHASE1 · RECRUITING · started Jun 21, 2024ClinicalTrials.gov NCT06257693 · fetched Nov 12, 2026
- Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 7, 2021ClinicalTrials.gov NCT04943536 · fetched Nov 12, 2026
- A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate CancerPHASE1 · COMPLETED · started Oct 11, 2020ClinicalTrials.gov NCT04284761 · fetched Nov 12, 2026